Ricciardi, G.R.R.; Russo, A.; Sanò, M.V.; Prestifilippo, A.; Russo, A.; Gebbia, V.; Blasi, L.; Giuffrida, D.; Scandurra, G.; Savarino, A.;
et al. Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study. Cancers 2025, 17, 2069.
https://doi.org/10.3390/cancers17132069
AMA Style
Ricciardi GRR, Russo A, Sanò MV, Prestifilippo A, Russo A, Gebbia V, Blasi L, Giuffrida D, Scandurra G, Savarino A,
et al. Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study. Cancers. 2025; 17(13):2069.
https://doi.org/10.3390/cancers17132069
Chicago/Turabian Style
Ricciardi, Giuseppina Rosaria Rita, Alessandro Russo, Maria Vita Sanò, Angela Prestifilippo, Antonio Russo, Vittorio Gebbia, Livio Blasi, Dario Giuffrida, Giuseppa Scandurra, Antonio Savarino,
and et al. 2025. "Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study" Cancers 17, no. 13: 2069.
https://doi.org/10.3390/cancers17132069
APA Style
Ricciardi, G. R. R., Russo, A., Sanò, M. V., Prestifilippo, A., Russo, A., Gebbia, V., Blasi, L., Giuffrida, D., Scandurra, G., Savarino, A., Butera, A., Borsellino, N., Verderame, F., Caruso, M., & Adamo, V.
(2025). Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study. Cancers, 17(13), 2069.
https://doi.org/10.3390/cancers17132069
